全文获取类型
收费全文 | 6130篇 |
免费 | 695篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 193篇 |
妇产科学 | 128篇 |
基础医学 | 939篇 |
口腔科学 | 253篇 |
临床医学 | 703篇 |
内科学 | 1614篇 |
皮肤病学 | 174篇 |
神经病学 | 406篇 |
特种医学 | 423篇 |
外科学 | 678篇 |
综合类 | 118篇 |
一般理论 | 4篇 |
预防医学 | 430篇 |
眼科学 | 148篇 |
药学 | 400篇 |
中国医学 | 2篇 |
肿瘤学 | 261篇 |
出版年
2021年 | 83篇 |
2020年 | 57篇 |
2019年 | 67篇 |
2018年 | 83篇 |
2017年 | 66篇 |
2016年 | 81篇 |
2015年 | 89篇 |
2014年 | 124篇 |
2013年 | 192篇 |
2012年 | 218篇 |
2011年 | 268篇 |
2010年 | 181篇 |
2009年 | 155篇 |
2008年 | 235篇 |
2007年 | 289篇 |
2006年 | 271篇 |
2005年 | 246篇 |
2004年 | 227篇 |
2003年 | 208篇 |
2002年 | 221篇 |
2001年 | 223篇 |
2000年 | 246篇 |
1999年 | 188篇 |
1998年 | 116篇 |
1997年 | 89篇 |
1996年 | 97篇 |
1995年 | 77篇 |
1994年 | 79篇 |
1993年 | 66篇 |
1992年 | 190篇 |
1991年 | 146篇 |
1990年 | 153篇 |
1989年 | 139篇 |
1988年 | 141篇 |
1987年 | 135篇 |
1986年 | 125篇 |
1985年 | 136篇 |
1984年 | 93篇 |
1983年 | 96篇 |
1982年 | 76篇 |
1981年 | 70篇 |
1980年 | 50篇 |
1979年 | 95篇 |
1978年 | 68篇 |
1977年 | 57篇 |
1976年 | 64篇 |
1975年 | 51篇 |
1972年 | 60篇 |
1971年 | 57篇 |
1970年 | 57篇 |
排序方式: 共有6906条查询结果,搜索用时 31 毫秒
141.
142.
143.
C. Scott Moss Ph.D. 《The International journal of clinical and experimental hypnosis》2013,61(2):59-66
A highly detailed account of the psychotherapy of one female hysterioa treatment failureis the stimulant for discussion of the genetics and dynamics of this nosology. The patient's symptomatology includes feelings of unreality, seizures, an embryo dual personality, and frigidity. Hypnosis revealed the experimental basis for these symptoms and associated adjustment di5iculties. The dynamics bear a remarkable resemblance to those advanced by Freud and Breuer, though issue is taken with several fundamental psychoanalytic concepts. The Discussion deals largely with the phenomenology of the female hysteric. It is concluded that the seemingly favorable prognosis of the hysteric is illusionary if the goal is characterologic change. 相似文献
144.
Hilary M. P. Fielder Stephen R. Palmer Celia Poon-king Nigel Moss Gary Coleman 《Archives of environmental & occupational health》2013,68(6):529-535
Residents near the Trecatti landfill site located in South Wales, United Kingdom, expressed concern about odors and health effects they attributed to site emissions. The authors compared routinely collected, population-based, health data from potentially exposed electoral wards (i.e., United Kingdom electoral tracts) with data from both wards nearby, matched for socioeconomic deprivation scores, and with wards where residents were likely to attend the same hospital. Mortality rates were higher for all causes and neoplastic diseases (but not respiratory disease) in the exposed wards, but there was no change in rates after the site opened. Hospital data revealed a transient increase in admissions for asthma during the 3 yr that preceded the peak in odor complaints. The birth prevalence of congenital malformations was raised in the exposed wards, but the authors could not exclude a possible artifact resulting from differences in reporting practices between hospitals. The absence of environmental monitoring in the community during the period of public concern was a significant weakness of this study. 相似文献
145.
146.
Brett A. Colson Inna N. Rybakova Ewa Prochniewicz Richard L. Moss David D. Thomas 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(50):20437-20442
We have determined the effects of myosin binding protein-C (MyBP-C) and its domains on the microsecond rotational dynamics of actin, detected by time-resolved phosphorescence anisotropy (TPA). MyBP-C is a multidomain modulator of striated muscle contraction, interacting with myosin, titin, and possibly actin. Cardiac and slow skeletal MyBP-C are known substrates for protein kinase-A (PKA), and phosphorylation of the cardiac isoform alters contractile properties and myofilament structure. To determine the effects of MyBP-C on actin structural dynamics, we labeled actin at C374 with a phosphorescent dye and performed TPA experiments. The interaction of all three MyBP-C isoforms with actin increased the final anisotropy of the TPA decay, indicating restriction of the amplitude of actin torsional flexibility by 15–20° at saturation of the TPA effect. PKA phosphorylation of slow skeletal and cardiac MyBP-C relieved the restriction of torsional amplitude but also decreased the rate of torsional motion. In the case of fast skeletal MyBP-C, its effect on actin dynamics was unchanged by phosphorylation. The isolated C-terminal half of cardiac MyBP-C (C5–C10) had effects similar to those of the full-length protein, and it bound actin more tightly than the N-terminal half (C0–C4), which had smaller effects on actin dynamics that were independent of PKA phosphorylation. We propose that these MyBP-C-induced changes in actin dynamics play a role in the functional effects of MyBP-C on the actin–myosin interaction. 相似文献
147.
148.
Margaret S. Herridge Marc Moss Catherine L. Hough Ramona O. Hopkins O. Joseph Bienvenu Elie Azoulay 《Intensive care medicine》2016,42(5):725-738
Outcomes after acute respiratory distress syndrome (ARDS) are similar to those of other survivors of critical illness and largely affect the nerve, muscle, and central nervous system but also include a constellation of varied physical devastations ranging from contractures and frozen joints to tooth loss and cosmesis. Compromised quality of life is related to a spectrum of impairment of physical, social, emotional, and neurocognitive function and to a much lesser extent discrete pulmonary disability. Intensive care unit-acquired weakness (ICUAW) is ubiquitous and includes contributions from both critical illness polyneuropathy and myopathy, and recovery from these lesions may be incomplete at 5 years after ICU discharge. Cognitive impairment in ARDS survivors ranges from 70 to 100 % at hospital discharge, 46 to 80 % at 1 year, and 20 % at 5 years, and mood disorders including depression and post-traumatic stress disorder (PTSD) are also sustained and prevalent. Robust multidisciplinary and longitudinal interventions that improve these outcomes are still uncertain and data in our literature are conflicting. Studies are needed in family members of ARDS survivors to better understand long-term outcomes of the post-ICU family syndrome and to evaluate how it affects patient recovery. 相似文献
149.
Jenie George B.A. Alon Barsheshet M.D. Arthur J. Moss M.D. David Martin M.D. Gregory Ouellet B.S. Scott McNitt M.S. Ilan Goldenberg M.D. 《Annals of noninvasive electrocardiology》2012,17(1):14-21
Background: Diabetes mellitus (DM) increases the risk for the development of both ischemic and nonischemic cardiomyopathy. We aimed to identify differences in response to cardiac resynchronization therapy with a defibrillator (CRT‐D) among DM patients with ischemic or nonischemic cardiomyopathy. Methods: Cox proportional hazards regression modeling was used to assess clinical response to CRT‐D (defined as CRT‐D vs. defibrillator‐only reduction in the risk of heart failure [HF] or death) and echocardiographic response (defined as percent reduction in left ventricular end diastolic and systolic volume [LVEDV and LVESV, respectively] at 12 month of follow‐up compared with baseline values) among 552 diabetic patients with ischemic (n = 367) or nonischemic (n = 185) cardiomyopathy enrolled in MADIT‐CRT. Results: The clinical benefit of CRT‐D was more pronounced among nonischemic patients (HR = 0.30 [P < 0.001] than among ischemic patients (HR = 0.59 [P = 0.004]; P for interaction = 0.10). Nonischemic patients also experienced significantly greater reductions in LVESV and LVEDV at 12 months with CRT‐D compared with ischemic patients (P < 0.001 for both). Subgroup analysis showed that the most pronounced reduction in HF or death with CRT‐D therapy occurred in nonischemic patients who were women (83% risk‐reduction [P < 0.001]), had a lower BMI (<30/kg/m2: 79% risk‐reduction [P < 0.001]), or had left bundle branch block at enrollment (82% risk‐reduction [P < 0.001]). Conclusions: The present study shows that treatment with CRT‐D in at‐risk cardiac patients with DM is associated with substantial reductions in the risk of HF or death and improvement in cardiac remodeling in those with ischemic and nonischemic cardiomyopathy, with a more pronounced benefit in patients with nonischemic disease. Ann Noninvasive Electrocardiol 2012;17(1):14–21 相似文献
150.